Beyond Design: AI-driven Inverse Stackup Optimization
Global PCB Connections: Following DFM Rules Leads to Better Boards
Elementary Mr. Watson: How to Reinvent Your Professional Journey
Endomag Renews Manufacturing Agreement with ITL Group
September 9, 2019 | ITL GroupEstimated reading time: 1 minute
Endomag has renewed a five-year manufacturing contract with ITL Group for on-going production of its commercially successful surgical guidance system, the Sentimag platform.
The Sentimag platform helps surgeons to mark, detect and accurately remove tumours or lymph nodes causing minimal damage to the breast tissue. The technology works like a metal detector, which when placed near the skin’s surface can detect Endomag’s magnetic seed (Magseed®) or magnetic lymph node tracer (Magtrace).
ITL Group successfully supported Endomag as it took the device from a proof of principle instrument to state-of-the-art medical technology. Endomag has won several awards for the design and production of the Sentimag® platform, including the Queen’s Award for Enterprise in Innovation in 2018.
"I am delighted to continue our relationship with the team at ITL. Their expertise in design, tooling and manufacture has helped fulfil our technology’s potential as we strive to make cancer care better for patients everywhere. I am looking forward to continuing to work together, as we grow to meet global demand for the Sentimag® system," said Eric Mayes, Endomag CEO.
ITL manufactures the platform in Britain for use all around the world. To this day, the Sentimag system is the world's most sensitive handheld magnetic probe, used in over 60,000 breast cancer procedures at over 400 hospitals in more than 30 countries.
"From humble beginnings as a spin-out from UCL, to now being one of ITL’s longest-standing customers, it has been an absolute pleasure to work alongside Eric and the team as they’ve grown from strength to strength. We’re delighted to secure another five years manufacturing with Endomag. They are a fantastic company to work alongside and we greatly value the opportunity to work with them longer term as they strive to improve the global standard of cancer care," ITL Managing Director Tom Cole said.
Share on:
Suggested Items
WiSA Technologies Inks Definitive Agreement to Acquire CompuSystems
12/27/2024 | BUSINESS WIREWiSA Technologies, Inc., which anticipates closing its acquisition of Datavault® intellectual property and information technology assets of privately held Data Vault Holdings Inc.® and changing its name to Datavault Inc.
Solar Powered Aircraft Achieves New Stratospheric Success
12/26/2024 | BAE SystemsA British-led team of engineers has taken a leap forward in the race to harness the stratosphere for earth observation and communications, completing a new series of test flights of BAE Systems’ High Altitude Pseudo Satellite (HAPS) Uncrewed Aerial System (UAS), PHASA-35®, in quick succession.
Modernizing TAURUS for the Bundeswehr
12/25/2024 | MBDAThe Bundeswehr and TAURUS Systems GmbH (a joint venture between MBDA and SAAB) have signed a contract for the maintenance and modernization of the TAURUS stand-off weapon system. The measures will ensure the weapon's operational readiness until at least 2045.
SIA Statement on Biden Administration’s Launch of Section 301 Trade Investigation Related to China’s Targeting of the Semiconductor Industry for Dominance
12/25/2024 | SIAThe Semiconductor Industry Association (SIA) released the following statement from SIA President and CEO John Neuffer regarding the Biden administration’s decision to launch a Section 301 trade investigation focused on China’s acts, policies, and practices related to targeting of the semiconductor industry for dominance.
Two Additional Boeing O3b mPOWER Satellites Successfully Communicating in Space
12/23/2024 | BoeingTwo more Boeing-built O3b mPOWER satellites are sending and receiving signals in space after launching from the Kennedy Space Center, Florida at 5:26 p.m.